Darbelife 200 Injection
Marketer
Hetero Drugs Ltd
Salt Composition
Darbepoetin alfa (200mcg)
Overview Darbelife 200 Injection
Erythropoiesis-stimulating Darbelife 200 Injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Administered under strict medical supervision, Darbelife 200 carries significant risk and requires expert management. Adherence to physician instructions is crucial. Common adverse reactions include abdominal discomfort, hypertension, skin rashes, injection site pain, dyspnea, cough, and peripheral swelling. Report severe headaches, visual disturbances, nausea, vomiting, or convulsions (indicative of dangerously high blood pressure) immediately. Regular blood tests monitoring electrolyte (e.g., potassium) levels, hemoglobin, and blood cell counts are essential. Discontinue use and consult your physician if experiencing respiratory distress or dermatological reactions. Prior to treatment, disclose any history of cardiac disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or intending to conceive individuals must discuss the drug's safety with their doctor.
Uses of Darbelife 200 Injection
Managing anemia in patients with chronic kidney disease | Addressing chemotherapy-induced anemia
Major Benefits of Darbelife 200 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Darbelife 200 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbelife 200 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Darbelife 200 Injection works:
Darbepoetin alfa injection (200 mcg) boosts red blood cell production. This erythropoiesis-stimulating agent acts on the bone marrow to increase red blood cell output.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darbelife 200 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darbelife 200 Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Darbelife 200 Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Darbelife 200 Injection.
KidneySAFE IF PRESCRIBED
Darbelife 200 Injection poses no safety concerns for individuals with renal impairment; no dosage modification is necessary.
LiverCAUTION
Individuals with hepatic impairment should use Darbelife 200 Injection cautiously; dose modification may be necessary. Physician consultation is advised.
What if you forget to take Darbelife 200 Injection :
Should you forget a Darbelife 200 Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darbelife 200 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Erythropoietin-stimulating drug |
3,018 People bought this recently